Research map: Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model

Back to the article

Papers in this map

  1. A New Equation to Estimate Glomerular Filtration Rate · Andrew S. Levey · 2009 · 26117 citations · Cited by this paper
  2. Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · 2026 · Related
  3. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018 · Keke Dang · 2024 · 616 citations · Cited by this paper
  4. Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · 2026 · Related
  5. Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS) · Jinquan Gong · 2022 · 362 citations · Cited by this paper
  6. Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · 2026 · Related
  7. Association of Lipids With Ischemic and Hemorrhagic Stroke · Xiaoying Gu · 2019 · 153 citations · Cited by this paper
  8. Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · 2026 · Related
  9. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study · Qiushi Ren · 2024 · 136 citations · Cited by this paper
  10. STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · 2026 · Related
  11. The triglyceride–glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis · Chenyang Li · 2025 · 131 citations · Cited by this paper
  12. Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · 2026 · Related
  13. Predictive capacity of triglyceride-glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review · Alice Divina Melo de Brito · 2020 · 114 citations · Cited by this paper
  14. Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study · 2026 · Related
  15. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride–glucose index in predicting cardiovascular disease risk: a cohort study · De-Gang Mo · 2025 · 113 citations · Cited by this paper
  16. Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies · 2026 · Related
  17. Lipid and lipoprotein measurements and the risk of ischemic vascular events · Aleksandra Pikula · 2015 · 98 citations · Cited by this paper
  18. Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis · 2026 · Related
  19. Changes in the combination of the triglyceride-glucose index and obesity indicators estimate the risk of cardiovascular disease · Xiaoqing Zhu · 2024 · 50 citations · Cited by this paper
  20. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease · Xin Gao · 2025 · 49 citations · Cited by this paper
  21. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China · Chao Wang · 2025 · 42 citations · Cited by this paper
  22. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries · Eleana Bolla · 2024 · 35 citations · Cited by this paper
  23. Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study · Shiyi Tao · 2025 · 35 citations · Cited by this paper
  24. Exploring the U-shaped nonlinear relationship of CHG index with metabolic syndrome and mortality risks in metabolic syndrome patients · Shouxin Wei · 2025 · 27 citations · Cited by this paper
  25. Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019 · Xiaozhe Chen · 2023 · 26 citations · Cited by this paper
  26. Association between estimated glucose disposal rate and prediction of cardiovascular disease risk among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study · Jing Tian · 2025 · 22 citations · Cited by this paper
  27. Higher Magnesium Depletion Score Increases the Risk of All-cause and Cardiovascular Mortality in Hypertension Participants · Jingjing Song · 2024 · 21 citations · Cited by this paper
  28. Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study · Yuting Zhang · 2026 · 18 citations · Cited by this paper
  29. Burden of Cardio-Cerebrovascular and Renal Diseases Attributable to Systolic Hypertension in France in 2021 · Clémence Grave · 2024 · 16 citations · Cited by this paper
  30. Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population · Ciaran Navin Kohli-Lynch · 2025 · 16 citations · Cited by this paper
  31. Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance? · Jiajun Qiu · 2025 · 14 citations · Cited by this paper
  32. Association of insulin resistance surrogates with disease severity and adverse outcomes in chronic thromboembolic pulmonary hypertension: a multicenter cohort study · Luyang Gao · 2025 · 13 citations · Cited by this paper
  33. Elucidating the heterogeneity of prediabetes through subphenotyping with a two-dimensional tree structure · Hong Lin · 2025 · 13 citations · Cited by this paper
  34. Association between the cholesterol, high-density lipoprotein, and glucose index and type 2 diabetes mellitus prevalence in US adults: A cross-sectional study based on National Health and Nutrition Examination Survey 2009–2018 · Zhe J. Zhang · 2025 · 12 citations · Cited by this paper
  35. Evaluating the role of CHG index in predicting stroke risk among adults with varying glucose regulation · Qun Xiao · 2025 · 12 citations · Cited by this paper
  36. Association of cholesterol, high-density lipoprotein, and glucose index and its modified indices with the risk of stroke: insights from CHARLS · Yuqi Zeng · 2025 · 12 citations · Cited by this paper
  37. Associations of cumulative exposure and dynamic trajectories of cholesterol-HDL-glucose (CHG) index with cardiovascular disease in middle-aged and older Chinese adults: a longitudinal analysis · Yuting Zhang · 2026 · 12 citations · Cited by this paper
  38. Cerebral Microbleeds and Their Association With Inflammation and Blood-Brain Barrier Leakage in Small Vessel Disease · Lupei Cai · 2025 · 10 citations · Cited by this paper
  39. Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial · Dorairaj Prabhakaran · 2025 · 9 citations · Cited by this paper

Source: OpenAlex (CC0)